Table 8.
Percentages of adverse reactions following each vaccination dose.
| Percentage of Adverse Events per Dose | |||
|---|---|---|---|
| Pain at the site of injection | 27 | ||
| Local erythema | 1.1 | ||
| BNT162b2 | Fever | 5.2 | |
| Urticaria | 1.7 | ||
| Other § | 10.3 | ||
| Pain at the site of injection | 31.3 | ||
| Local erythema | 5 | ||
| mRNA-1273 | Fever | 18.8 | |
| Urticaria | 0 | ||
| First dose | Other | 31.3 | |
| Pain at the site of injection | 18.2 | ||
| Local erythema | 0 | ||
| ChAdOx1-S | Fever | 36.4 | |
| Urticaria | 0 | ||
| Other | 18.2 | ||
| Pain at the site of injection | 0 | ||
| Local erythema | 0 | ||
| Ad26.COV2.S | Fever | 0 | |
| Urticaria | 0 | ||
| Other | 0 | ||
| Pain at the site of injection | 26 | ||
| Local erythema | 0.6 | ||
| BNT162b2 | Fever | 1.1 | |
| Urticaria | 6.6 | ||
| Other | 11 | ||
| Pain at the site of injection | 44.4 | ||
| Local erythema | 0 | ||
| Second dose | mRNA-1273 | Fever | 33.3 |
| Urticaria | 0 | ||
| Other | 27.8 | ||
| Pain at the site of injection | 0 | ||
| Local erythema | 0 | ||
| ChAdOx1-S | Fever | 0 | |
| Urticaria | 0 | ||
| Other | 0 | ||
| Pain at the site of injection | 54.2 | ||
| Local erythema | 1.7 | ||
| BNT162b2 | Fever | 23.7 | |
| Urticaria | 0 | ||
| Booster dose | Other | 22 | |
| Pain at the site of injection | 44.1 | ||
| Local erythema | 5.9 | ||
| mRNA-1273 | Fever | 26.5 | |
| Urticaria | 2.9 | ||
| Other | 41.2 | ||
§ Systemic reactions not included in the other categories (myalgia, fatigue).